GO:0009063 amino acid catabolic process: Breakdown Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009063 (amino acid catabolic process) describes the chemical reactions and pathways that break down amino acids, organic acids containing one or more amino substituents.
• Amino acid catabolism is central to energy production, nitrogen disposal, and the supply of carbon skeletons for gluconeogenesis and lipogenesis.
• The process is highly compartmentalized, with key steps occurring in the cytosol, mitochondria, and peroxisomes, and it is tightly regulated by hormonal and nutritional signals.
• Dysregulation of amino acid catabolism contributes to metabolic disorders, cancer, and neurological diseases, making it a major research and therapeutic target.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of catabolic enzymes and transporters in health and disease.
• Studying this process requires integrated methods such as metabolomics, flux analysis, and CRISPR library screening to map pathway dependencies.
Description
Amino acid catabolic process (GO:0009063) is the set of biochemical reactions that degrade amino acids into simpler molecules, thereby releasing energy and providing precursors for other metabolic pathways. This process is essential for maintaining nitrogen balance, supplying carbon skeletons for gluconeogenesis and fatty acid synthesis, and regulating cellular signaling. In mammals, amino acid catabolism occurs primarily in the liver, but also in the intestine, kidney, and muscle, with distinct tissue-specific roles. The breakdown of amino acids is not merely a disposal mechanism; it is a dynamic hub that integrates nutritional status with systemic metabolism. For researchers, understanding GO:0009063 is critical because its dysregulation is linked to inborn errors of metabolism, cancer cachexia, and metabolic syndrome. Moreover, microbial amino acid catabolism in the gut influences host health, highlighting the broad relevance of this process across organisms. This article provides a comprehensive overview of the pathways, key genes, regulatory mechanisms, and experimental models used to study amino acid catabolic process, with a focus on CRISPR-based approaches for functional genomics.
amino acid catabolic process At A Glance
| GO ID | GO:0009063 |
|---|---|
| GO term | amino acid catabolic process |
| Ontology | biological_process |
| Synonym | amino acid breakdown; amino acid catabolism; amino acid degradation; cellular amino acid catabolic process |
| Major function | Breakdown of amino acids to release energy and supply carbon skeletons for gluconeogenesis, lipogenesis, and other biosynthetic pathways |
| Subcellular locations | Cytosol, mitochondria, peroxisomes, and extracellular space (for microbial catabolism) |
| Key enzymes | Transaminases, glutamate dehydrogenase, branched-chain alpha-keto acid dehydrogenase, and various amino acid oxidases |
| Regulation | Hormonal (insulin, glucagon, glucocorticoids), nutritional, and allosteric regulation |
| Related diseases | Maple syrup urine disease, phenylketonuria, cancer cachexia, and metabolic syndrome |
What Is GO:0009063?
According to the Gene Ontology, amino acid catabolic process (GO:0009063) is defined as the chemical reactions and pathways resulting in the breakdown of amino acids, which are organic acids containing one or more amino substituents. This encompasses the enzymatic removal of the amino group (deamination), the conversion of the resulting carbon skeleton into intermediates of central metabolism, and the subsequent oxidation or interconversion of these intermediates. The process includes both general and specific pathways for individual amino acids, such as transamination, oxidative deamination, and decarboxylation, and it is often coupled to the urea cycle for nitrogen excretion.
Why Is amino acid catabolic process Important in Cell Biology?
Amino acid catabolic process is fundamental to cellular and organismal homeostasis because it governs the utilization of amino acids as energy substrates and as precursors for gluconeogenesis, lipogenesis, and neurotransmitter synthesis. It also plays a critical role in nitrogen disposal through the urea cycle, preventing toxic ammonia accumulation. In immune cells, amino acid catabolism influences inflammatory responses and immune cell activation, linking metabolism to immunity. In the intestine, microbial amino acid catabolism produces metabolites that affect host physiology and disease susceptibility. Consequently, understanding this process is essential for developing therapies for metabolic disorders, cancer, and infectious diseases.
• Provides energy during fasting or low-carbohydrate states by feeding carbon skeletons into the TCA cycle.
• Supplies substrates for gluconeogenesis, maintaining blood glucose levels.
• Enables nitrogen excretion via the urea cycle, preventing hyperammonemia.
• Supports neurotransmitter synthesis and brain function through amino acid precursors.
• Regulates immune cell function and inflammation through metabolic reprogramming.
• Influences gut microbiota composition and host-microbe interactions.
• Dysregulation is implicated in cancer cachexia and tumor metabolism.
• Inborn errors of amino acid catabolism cause severe metabolic diseases, often diagnosed in newborns.
• Serves as a target for therapeutic intervention in metabolic syndrome and diabetes.
• Microbial amino acid catabolism is important for food fermentation and probiotic development.
What Happens During amino acid catabolic process?
Transamination and Deamination
In simple terms: The amino group is removed from amino acids and transferred to other molecules.
The first step in amino acid catabolism is often the removal of the alpha-amino group. Transaminases (aminotransferases) catalyze the transfer of the amino group from an amino acid to an alpha-keto acid, typically alpha-ketoglutarate, forming glutamate and a new alpha-keto acid. Glutamate can then undergo oxidative deamination by glutamate dehydrogenase, releasing free ammonia and regenerating alpha-ketoglutarate. This ammonia enters the urea cycle for excretion. Alternatively, amino acids can be directly deaminated by amino acid oxidases, producing ammonia and hydrogen peroxide. These reactions are critical for nitrogen disposal and for generating carbon skeletons that enter central metabolic pathways.
Carbon Skeleton Oxidation
In simple terms: The remaining carbon parts of amino acids are broken down to make energy.
After deamination, the carbon skeletons of amino acids are converted into intermediates of the citric acid cycle, such as pyruvate, acetyl-CoA, acetoacetyl-CoA, alpha-ketoglutarate, succinyl-CoA, fumarate, and oxaloacetate. These intermediates can be oxidized for energy production or used for gluconeogenesis and lipogenesis. For example, alanine is converted to pyruvate, which can enter gluconeogenesis, while leucine and lysine are ketogenic, producing acetyl-CoA and acetoacetate. The branched-chain alpha-keto acid dehydrogenase complex catalyzes the oxidative decarboxylation of branched-chain amino acids (leucine, isoleucine, valine). This step is tightly regulated and defects lead to maple syrup urine disease.
Urea Cycle and Nitrogen Disposal
In simple terms: Toxic ammonia is converted into urea for safe excretion.
The ammonia released from amino acid deamination is toxic and must be converted to urea in the liver through the urea cycle. The urea cycle involves five enzymes: carbamoyl phosphate synthetase I, ornithine transcarbamylase, argininosuccinate synthetase, argininosuccinate lyase, and arginase. This pathway is essential for nitrogen balance, and its dysfunction causes hyperammonemia and related neurological disorders. In addition to urea, some nitrogen is excreted as uric acid (in birds and reptiles) or as ammonium (in fish), but in mammals, urea is the primary vehicle.
Tissue-Specific Catabolism
In simple terms: Different organs break down amino acids in different ways.
Amino acid catabolism is compartmentalized across tissues. The liver is the major site for urea cycle and for catabolism of most amino acids. The intestine catabolizes dietary amino acids, particularly glutamate, glutamine, and aspartate, providing energy for enterocytes and influencing systemic amino acid availability. The kidney contributes to glutamine catabolism, producing ammonia for acid-base balance. Muscle tissue catabolizes branched-chain amino acids, which are then released as alanine and glutamine for hepatic gluconeogenesis. This inter-organ cooperation is essential for metabolic homeostasis during fasting and exercise.
Microbial Amino Acid Catabolism
In simple terms: Gut bacteria also break down amino acids, producing important metabolites.
Lactic acid bacteria and other gut microbes possess diverse amino acid catabolic pathways that convert amino acids into flavor compounds, biogenic amines, and short-chain fatty acids. These microbial activities influence host health by producing metabolites such as indole derivatives from tryptophan, which act as signaling molecules. In the intestine, microbial amino acid catabolism competes with host absorption and can affect the availability of amino acids for the host. Understanding these microbial pathways is important for probiotic development and for treating dysbiosis.
Key Genes Involved in GO:0009063 amino acid catabolic process
The following genes encode key enzymes and transporters involved in amino acid catabolic process, and they are frequently studied using CRISPR-based models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GOT1 | Cytosolic aspartate aminotransferase; transfers amino group from aspartate to alpha-ketoglutarate | Target in cancer metabolism; knockout affects redox balance and proliferation |
| GOT2 | Mitochondrial aspartate aminotransferase; participates in malate-aspartate shuttle and amino acid catabolism | Knockout models reveal mitochondrial metabolic flexibility |
| GLUD1 | Glutamate dehydrogenase; oxidative deamination of glutamate | Regulates ammonia handling and insulin secretion; linked to hyperinsulinism |
| BCKDHA | Branched-chain alpha-keto acid dehydrogenase E1 alpha subunit; catabolism of branched-chain amino acids | Mutations cause maple syrup urine disease; knockout models for metabolic studies |
| BCKDHB | Branched-chain alpha-keto acid dehydrogenase E1 beta subunit | Similar to BCKDHA; targets for metabolic disease research |
| DBT | Dihydrolipoamide branched chain transacylase E2; component of BCKDH complex | Defects cause maple syrup urine disease; used in structure-function studies |
| DLD | Dihydrolipoamide dehydrogenase; component of BCKDH and pyruvate dehydrogenase complexes | Links amino acid catabolism to energy metabolism; knockout is lethal |
| HGD | Homogentisate 1,2-dioxygenase; tyrosine catabolism | Mutations cause alkaptonuria; model for metabolic disorders |
| FAH | Fumarylacetoacetate hydrolase; tyrosine catabolism | Defects cause tyrosinemia type I; widely used in liver disease models |
| PAH | Phenylalanine hydroxylase; converts phenylalanine to tyrosine | Mutations cause phenylketonuria; classic target for metabolic engineering |
| SLC7A5 | L-type amino acid transporter 1; transports large neutral amino acids | Overexpressed in cancer; knockout reduces tumor growth |
| SLC1A5 | Alanine-serine-cysteine transporter 2; glutamine transport | Essential for glutamine catabolism in cancer cells |
| SLC25A12 | Mitochondrial aspartate-glutamate carrier; part of malate-aspartate shuttle | Knockout affects amino acid catabolism and energy metabolism |
| SLC25A13 | Citrin; aspartate-glutamate carrier in urea cycle | Defects cause citrin deficiency; model for hyperammonemia |
| OTC | Ornithine transcarbamylase; urea cycle enzyme | Mutations cause OTC deficiency; common target for gene therapy |
| ASS1 | Argininosuccinate synthetase 1; urea cycle enzyme | Deficiency causes citrullinemia; knockout models for liver disease |
| ASL | Argininosuccinate lyase; urea cycle enzyme | Defects cause argininosuccinic aciduria; models for neurological involvement |
| ARG1 | Arginase 1; final urea cycle enzyme | Deficiency causes hyperargininemia; target in cancer immunotherapy |
How Is amino acid catabolic process Regulated?
Amino acid catabolic process is regulated at multiple levels to match metabolic demand. Hormonal signals such as glucagon and glucocorticoids promote catabolism during fasting, while insulin suppresses it in the fed state. Allosteric regulation of key enzymes, such as glutamate dehydrogenase and branched-chain alpha-keto acid dehydrogenase, provides rapid control. Transcriptional regulation via nutrient-sensing pathways, including mTORC1 and the integrated stress response, modulates the expression of catabolic enzymes and transporters. In the liver, the urea cycle is regulated by substrate availability and by hormonal signals that coordinate nitrogen disposal with gluconeogenesis. Additionally, amino acid transporters in the plasma membrane control the flux of amino acids into catabolic pathways, and their expression is often altered in cancer and metabolic diseases.
amino acid catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCKDHA | Maple syrup urine disease; accumulation of branched-chain amino acids | Knockout mouse or cell model to study neurotoxicity and metabolic rescue |
| PAH | Phenylketonuria; phenylalanine accumulation | Point-mutation knock-in to model common PAH variants |
| FAH | Tyrosinemia type I; liver failure and hepatocellular carcinoma | Knockout mouse for liver disease and gene therapy |
| OTC | Ornithine transcarbamylase deficiency; hyperammonemia | Knockout hepatocytes for urea cycle studies |
| SLC7A5 | Cancer; amino acid transport and mTORC1 activation | Overexpression and knockout models for tumor growth |
Inborn Errors of Amino Acid Catabolism
Mutations in genes encoding amino acid catabolic enzymes cause severe metabolic disorders, often presenting in infancy. Maple syrup urine disease results from defects in the branched-chain alpha-keto acid dehydrogenase complex (BCKDHA, BCKDHB, DBT, DLD), leading to accumulation of branched-chain amino acids and neurotoxicity. Phenylketonuria, caused by PAH deficiency, results in phenylalanine accumulation and intellectual disability if untreated. Tyrosinemia type I, due to FAH deficiency, causes liver failure and hepatocellular carcinoma. These disorders highlight the critical importance of amino acid catabolism for normal physiology and the need for accurate genetic models to study them.
Cancer Metabolism
Many cancer cells reprogram amino acid catabolism to support rapid proliferation. For example, glutamine catabolism via GOT1 and GLUD1 provides NADPH and carbon for biosynthetic pathways. Overexpression of amino acid transporters such as SLC7A5 and SLC1A5 is common in tumors and correlates with poor prognosis. Targeting these pathways with CRISPR knockout models has revealed dependencies that can be exploited therapeutically. In addition, amino acid catabolism in immune cells influences anti-tumor immunity, making it a target for immunotherapy.
Neurological and Metabolic Disorders
Dysregulated amino acid catabolism contributes to neurological diseases beyond classic inborn errors. Hyperammonemia from urea cycle defects (e.g., OTC, ASS1, ASL) causes cerebral edema and cognitive impairment. Altered branched-chain amino acid catabolism is associated with insulin resistance and diabetes. In the gut, microbial amino acid catabolism produces neuroactive compounds that may influence brain function via the gut-brain axis. These connections underscore the broad impact of amino acid catabolism on human health.
From amino acid catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GOT1 affect cancer cell proliferation? | CRISPR knockout in cancer cell lines |
| How do point mutations in PAH alter enzyme activity? | CRISPR point mutation knock-in in hepatocytes |
| Can overexpression of SLC7A5 drive tumorigenesis? | CRISPR knock-in of a strong promoter or cDNA overexpression |
| What is the role of BCKDHA in branched-chain amino acid catabolism? | Knockout mouse model |
| How does OTC deficiency affect urea cycle flux? | CRISPR knockout in primary hepatocytes |
| Does tagging of GLUD1 reveal its subcellular localization? | Knock-in of fluorescent tag (e.g., GFP) |
How to Study the amino acid catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Metabolomics (LC-MS/GC-MS) | Levels of amino acids and catabolic intermediates | Profiling metabolic changes in knockout cells |
| Stable isotope tracing | Flux through catabolic pathways | Determining carbon fate in cancer cells |
| RNA-seq | Transcript levels of catabolic genes | Identifying regulatory changes in disease models |
| CRISPR library screening | Essential genes for catabolism | Discovering new targets in metabolic pathways |
| Proteomics | Protein abundance of enzymes | Validating expression changes |
| Enzyme activity assay | Catalytic activity of specific enzymes | Measuring GDH or BCKDH activity |
| Fluorescence microscopy | Subcellular localization of tagged enzymes | Studying mitochondrial vs. cytosolic isoforms |
| Genetically encoded sensors | Real-time metabolite dynamics | Monitoring amino acid levels in live cells |
Metabolomics and Flux Analysis
Metabolomics using mass spectrometry can quantify amino acids and their catabolic intermediates in cells and tissues. Stable isotope tracing with 13C- or 15N-labeled amino acids allows flux analysis through catabolic pathways, revealing how carbon and nitrogen are distributed. These methods are essential for understanding the dynamic regulation of amino acid catabolism in health and disease.
Genomic and Transcriptomic Profiling
RNA-seq and single-cell RNA-seq can identify expression changes in amino acid catabolic genes across conditions or tissues. CRISPR library screening combined with RNA-seq can uncover genes that are essential for catabolism under specific stresses. These approaches help map the regulatory networks controlling amino acid catabolism.
Proteomics and Enzyme Activity Assays
Proteomics can quantify protein levels of catabolic enzymes, while enzyme activity assays measure their catalytic capacity. For example, glutamate dehydrogenase activity can be measured spectrophotometrically by NADH formation. These methods validate findings from genetic screens and provide functional insights.
Imaging and Subcellular Localization
Fluorescence microscopy with tagged enzymes (e.g., GFP knock-in) can reveal subcellular localization of catabolic enzymes, such as mitochondrial vs. cytosolic isoforms. Live-cell imaging can track dynamic changes in metabolite levels using genetically encoded sensors. These techniques complement biochemical assays to provide spatial context.
How CRISPR Can Be Used to Study GO:0009063 amino acid catabolic process
Knockout
CRISPR knockout is used to completely ablate genes involved in amino acid catabolism, such as GOT1, GLUD1, or BCKDHA, to study their loss-of-function phenotypes. Knockout cell lines and mouse models have revealed essential roles in energy metabolism, nitrogen disposal, and cancer cell survival. These models are valuable for validating drug targets and understanding disease mechanisms.
Point Mutation
CRISPR point mutation knock-in introduces specific disease-associated mutations, such as those in PAH or OTC, to model inborn errors of metabolism. This approach allows precise dissection of how single amino acid changes affect enzyme activity, stability, and pathway flux. Point mutation models are also used to study drug resistance and personalized medicine.
Knock-in
CRISPR knock-in can insert tags (e.g., GFP, FLAG) or reporter cassettes into endogenous loci to track expression and localization of catabolic enzymes. Knock-in of promoter-reporter constructs enables live-cell imaging of pathway activity. This technique is also used to create conditional alleles for tissue-specific studies.
Overexpression
CRISPR-mediated overexpression (e.g., via safe-harbor locus insertion) is used to study gain-of-function effects of amino acid transporters or enzymes, such as SLC7A5 or GLUD1. Overexpression models help identify oncogenic potential and metabolic reprogramming. They complement knockout studies to provide a full picture of gene function.
How EDITGENE Supports amino acid catabolic process Research
Researchers studying amino acid catabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease progression, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes in the context of amino acid catabolism.
Contact EDITGENE today to design your custom CRISPR model for amino acid catabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| BCKDK Knockout HEK293 Cell Line | EDJ-KQ1127 | Human | 10295 | Details Get a Quote |
| IL4I1 Knockout HEK293 Cell Line | EDJ-KQ3808 | Human | 259307 | Details Get a Quote |
| ALDH7A1 Knockout HEK293 Cell Line | EDJ-KQ4111 | Human | 501 | Details Get a Quote |
| CRYM Knockout HEK293 Cell Line | EDJ-KQ4359 | Human | 1428 | Details Get a Quote |
| DAO Knockout HEK293 Cell Line | EDJ-KQ4419 | Human | 1610 | Details Get a Quote |
| ETFA Knockout HEK293 Cell Line | EDJ-KQ4558 | Human | 2108 | Details Get a Quote |
| GCDH Knockout HEK293 Cell Line | EDJ-KQ4688 | Human | 2639 | Details Get a Quote |
| AADAT Knockout HEK293 Cell Line | EDJ-KQ10956 | Human | 51166 | Details Get a Quote |
| PIPOX Knockout HEK293 Cell Line | EDJ-KQ11004 | Human | 51268 | Details Get a Quote |
| DHTKD1 Knockout HEK293 Cell Line | EDJ-KQ13149 | Human | 55526 | Details Get a Quote |
| ENOSF1 Knockout HEK293 Cell Line | EDJ-KQ13288 | Human | 55556 | Details Get a Quote |
| BCKDK Knockout HCT 116 Cell Line | EDJ-KQ18979 | Human | 10295 | Details Get a Quote |
| ALDH7A1 Knockout A-549 Cell Line | EDJ-KQ25169 | Human | 501 | Details Get a Quote |
| GCDH Knockout A-549 Cell Line | EDJ-KQ26152 | Human | 2639 | Details Get a Quote |
| ETFA Knockout A-549 Cell Line | EDJ-KQ27199 | Human | 2108 | Details Get a Quote |
Displaying Records 1 To 15 Of 52 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About amino acid catabolic process
What is amino acid catabolic process?
Amino acid catabolic process (GO:0009063) is the set of biochemical reactions that break down amino acids into simpler molecules, releasing energy and providing carbon skeletons for other pathways.
What genes are involved in amino acid catabolic process?
Key genes include GOT1, GOT2, GLUD1, BCKDHA, BCKDHB, DBT, DLD, PAH, FAH, HGD, OTC, ASS1, ASL, ARG1, and amino acid transporters such as SLC7A5 and SLC1A5.
Why is amino acid catabolism important for health?
It maintains nitrogen balance, provides energy during fasting, supports gluconeogenesis, and influences immune function and gut health.
What diseases are linked to defects in amino acid catabolism?
Inborn errors such as maple syrup urine disease, phenylketonuria, tyrosinemia, and urea cycle disorders, as well as cancer and metabolic syndrome.
How is amino acid catabolic process regulated?
It is regulated by hormones (insulin, glucagon), nutrient-sensing pathways (mTORC1, integrated stress response), and allosteric control of key enzymes.
What methods are used to study amino acid catabolism?
Metabolomics, stable isotope tracing, RNA-seq, proteomics, enzyme activity assays, and CRISPR screening are commonly used.
Can CRISPR be used to study amino acid catabolic genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies of these genes.
What is the role of the urea cycle in amino acid catabolism?
The urea cycle converts toxic ammonia released from amino acid deamination into urea for excretion, preventing hyperammonemia.
How does the gut microbiome contribute to amino acid catabolism?
Gut bacteria catabolize amino acids into metabolites such as short-chain fatty acids and indoles, influencing host physiology.
What are the key research tools for amino acid catabolism?
CRISPR-engineered cell models, metabolomics platforms, and bioinformatics pipelines are essential for dissecting pathways and identifying therapeutic targets.
Conclusion
Amino acid catabolic process (GO:0009063) is a cornerstone of cellular metabolism, integrating energy production, nitrogen disposal, and biosynthetic precursor supply. Its dysregulation underlies a wide range of human diseases, from inborn errors of metabolism to cancer and neurological disorders. Advances in CRISPR-based models and multi-omics technologies are accelerating our understanding of this process and enabling the development of targeted therapies. EDITGENE's comprehensive services support researchers in generating precise genetic models to study amino acid catabolism and translate findings into clinical applications.
References
- 1. Chandel NS. 2021. Amino Acid Metabolism.. Cold Spring Harb Perspect Biol 13(4) PMID: 33795250
- 2. Paulusma CC et al.. 2022. Amino acid metabolism, transport and signalling in the liver revisited.. Biochem Pharmacol 201:115074 PMID: 35568239
- 3. Bröer S. 2023. Intestinal Amino Acid Transport and Metabolic Health.. Annu Rev Nutr 43:73-99 PMID: 37285555
- 4. Cibrian D et al.. 2021. Editorial: Amino Acid Transport and Metabolism During Homeostasis and Inflammation.. Front Immunol 12:833258 PMID: 35111170
- 5. Broquist HP. 1976. Amino acid metabolism.. Nutr Rev 34(10):289-93 PMID: 137369
- 7. Fernández M et al.. 2006. Amino acid catabolic pathways of lactic acid bacteria.. Crit Rev Microbiol 32(3):155-83 PMID: 16893752
- 8. Bröer S et al.. 2018. Amino Acid Transport Across the Mammalian Intestine.. Compr Physiol 9(1):343-373 PMID: 30549024
